![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
October 19, 2023
Advanced Practice Providers Working Group debuts soon; community-focused column highlights genetic testing challenges; real-world data efforts accelerate
October 19, 2023
Through a series of blood tests and patient questionnaires, this prospective observational study examines how exposures to trauma and other adverse life experiences alter the activity of genes, immune cells, and subsequent health outcomes
October 19, 2023
This randomized phase 3 trial explores repeated focused radiation to control disease and spare patients with renal cell carcinoma from systemic therapy for months or even years
October 19, 2023
This randomized phase 2 study is assessing if chemotherapy plus immunotherapy is superior to immunotherapy alone for patients with operable MSI-H/dMMR gastric and/or gastroesophageal junction cancer
October 19, 2023
Following the recent Nature Medicine publication of lessons from the NCI-MATCH trial, two new podcasts discuss the pitfalls and promises of precision oncology—and opportunities to guide the field as it moves forward
October 19, 2023
Matthias Weiss, MD, of ThedaCare, and Kim Reiss, MD, of the University of Pennsylvania, discuss current trends in precision oncology
October 19, 2023
These four leukemia treatment trials and an observational study of myelodysplastic syndromes are all open and enrolling patients
October 19, 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more